UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 447.6 EUR -0.16%

Market Cap: €12.6B

U	United Therapeutics Corp SWB:UTH	US
	DroneShield Ltd ASX:DRO	AU
	X-Fab Silicon Foundries Europese Vennootschap PAR:XFAB	BE
B	Blu Label Unlimited Group Ltd JSE:BLU	ZA

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

88%

Declining Gross Margin

89% > 86%

Exceptional Operating Margin

44%

Strong 3Y Average Operating Margin

48%

Declining Operating Margin

50% > 44%

Exceptional Net Margin

42%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

41% > 42%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

35% > 34%

Positive ROE

19%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

29%

ROIC is Increasing

26% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.